| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
Current Issue: 2026 , Vol 64 , Num 4
| Editor-in-Chief: | Gülden Zehra Omurtag |
| Associate Editors: | Sevde Nur Biltekin Kaleli, Betül Şirin Karakaya |
| Copy Editors: | Ayşe Çalış, Ayşenur Ölmez, Fatma Sarı, Hikmet Gülben Güç, İsmet Berrak Altunçul, Melih Buğra Ağ, Melike Zeynep Ünükür, Meryem Nur Baş, Nezahat Nazlı Okay, Öykü Eytemiş, Özce Esma Pala Çamlı, Petek Nur Abiz, Selim Gürsoy, Sümeyye Elif Kahya, Tuğba Arslan |
| Online ISSN: | 1307-2080 |
| Frequency: | 4 issues / year |
| Abbreviation: | Acta Pharm Sci |
| Publisher: | Behalf of the İstanbul Medipol University Responsible Prof. Sabahattin Aydın, MD |
| Contact: | editor@actapharmsci.com |
ACTA Pharmaceutica Sciencia
Senolytic and senomorphic drugs: The future value, importance of nano drug delivery systems and quantum dots.
Investigation of the antimicrobial and cytotoxic effects of Viscum album (mistletoe) extracts.
The role of thymic stromal lymphopoietin (TSLP): A predictive biomarker for severity and poor control in asthmatic Iraqi patients.
Effects of oral non-toxic subchronic ochratoxin A exposure on brown adipose tissue function in female mice.
Differential apoptosis-associated responses of neurons and glial cells to cisplatin in primary cortical cultures.
Synergistic and antagonistic effects of different bee products on coagulation mechanism: In vitro prothrombin time analysis using the Quick method.
Design and optimization of HPMC/EC-diclofenac sodium transdermal patches.
In silico exploration of Diospyros malabarica phytochemicals as multi-target therapeutics against prostate cancer: Network pharmacology, molecular docking and molecular dynamics simulation.
Evaluation of fonio and sweet potato starches, and sodium alginate blends as polymers in metformin microbead formulation.
PHAR-COV: Development and validation of a pandemic-specific pharmacist response scale.
The significance of vascular endothelial growth factor (VEGF) levels in the early detection of breast cancer.
Investigation of the antimicrobial and cytotoxic effects of Viscum album (mistletoe) extracts.
The role of thymic stromal lymphopoietin (TSLP): A predictive biomarker for severity and poor control in asthmatic Iraqi patients.
Effects of oral non-toxic subchronic ochratoxin A exposure on brown adipose tissue function in female mice.
Differential apoptosis-associated responses of neurons and glial cells to cisplatin in primary cortical cultures.
Synergistic and antagonistic effects of different bee products on coagulation mechanism: In vitro prothrombin time analysis using the Quick method.
Design and optimization of HPMC/EC-diclofenac sodium transdermal patches.
In silico exploration of Diospyros malabarica phytochemicals as multi-target therapeutics against prostate cancer: Network pharmacology, molecular docking and molecular dynamics simulation.
Evaluation of fonio and sweet potato starches, and sodium alginate blends as polymers in metformin microbead formulation.
PHAR-COV: Development and validation of a pandemic-specific pharmacist response scale.
The significance of vascular endothelial growth factor (VEGF) levels in the early detection of breast cancer.
Acta Pharmaceutica Sciencia is licensed under a Creative Acta Pharmaceutica Sciencia is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
